ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
Sector - Healthcare
Equity
-
Last updated on 2023-01-23
3Y returns
+18.44%
| ₹15.49 Latest NAV | ₹0.11 1D Change | ₹2513.92 AUM |
|---|---|---|
| Very High Risk Risk Profile | ₹100 Min SIP | ₹5000 Min Lumpsum |
| None Lock-in period | 1.21% Expense Ratio | 1.0% before 15 Days Exit Load |
Price Chart
-3.50 1Y return
Loading...
Top Holdings
Sun Pharmaceuticals Industries Ltd
16.94%
Dr Reddy's Laboratories Ltd
8.26%
Lupin Ltd
5.09%
Apollo Hospitals Enterprise Ltd
4.91%
Alkem Laboratories Ltd
4.81%
View All
Sector Breakdown
Healthcare
92.92%
Financial Services
4.31%
Fund Manager
Dharmesh Kakkad
Sharmila D’mello
Investment Objective
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Download Scheme Document